๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Lymphoma

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites๐Ÿ“ Santa Rosa๐Ÿ“ Hartford๐Ÿ“ Washington D.C. VM Oncology, LLC ยท Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 A Real World Study of Ensartinib in Advanced ALK-positive NSCLC NCT05498064n/a1 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Ensartinib A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Lake Mary๐Ÿ“ Lebanon 7 Hills Pharma, LLC ยท Tests: Alintegimod, Ipilimumab, Nivolumab A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPฮฑ-CD47 Pathway, in Solid or Hematological Tumors NCT05892718Phase 18 sites๐Ÿ“ Port Saint Lucie๐Ÿ“ Huntersville๐Ÿ“ Greenville FBD Biologics Limited ยท Tests: HCB101 Odronextamab in Low Tumor Volume Advanced FL NCT07128641Phase 21 site๐Ÿ“ Boston Gottfried von Keudell, MD PhD ยท Tests: Odronextamab Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma NCT06745076Phase 26 sites๐Ÿ“ Irvine๐Ÿ“ Palo Alto๐Ÿ“ Boston University of Washington ยท Tests: Biospecimen Collection, Computed Tomography, Dacarbazine, Doxorubicin, Echocardiography Test Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression NCT07155226Phase 1, Phase 230 sites๐Ÿ“ Decatur๐Ÿ“ New York๐Ÿ“ Chapel Hill AstraZeneca ยท Tests: AZD3632, Posaconazole Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: CD146/HER2 CAR-T cells A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-1607, Paclitaxel Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy NCT07426484Phase 42 sites๐Ÿ“ Boston๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Cosibelimab, Prednisone, Sirolimus, Everolimus Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors NCT06132503Phase 11 site๐Ÿ“ West Valley City Lantern Pharma Inc. ยท Tests: LP-284 JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma NCT07603479Phase 11 site๐Ÿ“ Beijing Jecho Biopharmaceuticals Co., Ltd. ยท Tests: JL19001, subcutaneous injection, 1 ฮผg/kg, JL19001, subcutaneous injection, 5 ฮผg/kg, JL19001, subcutaneous injection,10 โ€ฆ A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL) NCT04771507Phase 1, Phase 29 sites๐Ÿ“ Trondheim๐Ÿ“ Falun๐Ÿ“ Gรคvle Jeanette Lundin ยท Tests: Ibrutinib Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma NCT05949931Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Concurrent penpulimab and AVD, Sequential penpulimab and AVD Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naรฏve Advanced Stage Follicular Lymphoma NCT07126678NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: zanubrutinib, bendamustine, and obinutuzumab Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma NCT06755450Phase 119 sites๐Ÿ“ Vadodara๐Ÿ“ Jhajjar๐Ÿ“ Bangalore Aurigene Discovery Technologies Limited ยท Tests: AUR112 The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease NCT06795815NA1 site๐Ÿ“ Reggio Emilia Azienda USL Reggio Emilia - IRCCS ยท Tests: Go Wish Game A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma๏ผˆKeyplus-001๏ผ‰ NCT05357651Phase 11 site๐Ÿ“ Shanghai L & L Bio Co., Ltd., Ningbo, China ยท Tests: LB1410 Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL NCT07494565Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Celecoxib Combined with R-CHOP, R-CHOP A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor NCT06615193Phase 18 sites๐Ÿ“ Zhengzhou๐Ÿ“ Suzhou๐Ÿ“ Suzhou Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. ยท Tests: HDM2005 Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies NCT04068597Phase 1, Phase 239 sites๐Ÿ“ Atlanta๐Ÿ“ Indianapolis๐Ÿ“ Bethesda CellCentric Ltd. ยท Tests: CCS1477, Pomalidomide, Dexamethasone, Azacitidine, Venetoclax A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies NCT06971523Phase 1, Phase 21 site๐Ÿ“ Beijing CytosinLab Therapeutics Co., Ltd. ยท Tests: CTS3497 Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) NCT03297606Phase 210 sites๐Ÿ“ Edmonton๐Ÿ“ Kelowna๐Ÿ“ Vancouver Canadian Cancer Trials Group ยท Tests: Olaparib, Dasatinib, Nivolumab plus Ipilimumab, Axitinib, Bosutinib A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma NCT05341557Phase 14 sites๐Ÿ“ Chaoyang๐Ÿ“ Cangzhou๐Ÿ“ Tianjin Betta Pharmaceuticals Co., Ltd. ยท Tests: BPI-371153 An Engineered Sirpฮฑ Fused to Anti-Pd-L1 And Tgf-ฮฒ Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors NCT06487624Phase 17 sites๐Ÿ“ Greenville๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou FBD Biologics Limited ยท Tests: HCB301 Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma NCT05833893Phase 21 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: XPO1 inhibitor Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study NCT06534762Phase 21 site๐Ÿ“ Hangzhou Zhejiang Provincial People's Hospital ยท Tests: Mirabegron Remote Monitoring and Symptom Management Digital Application NCT07553572NA1 site๐Ÿ“ Boston Patrick C. Johnson, MD ยท Tests: ASSIST phone application SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas NCT07222631Phase 1, Phase 21 site๐Ÿ“ La Jolla University of California, San Diego ยท Tests: SB-4826, Rituximab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy